HomeORGANIZATION
ORGANIZATION

Wrong Policies Could Drive Investments Out of Japan amid China’s Rise, PhRMA Int’l Advocacy Chief Warns
(Nov.6.2018)

Brian Toohey, Senior Vice President for International Advocacy, PhRMA
For pharmaceutical companies, Japan has long been a priority market in Asia, but the “wrong type” of policies being rolled out in the country in recent years could change all that, warns Brian Toohey, chief of international advocacy at PhRMA ...
(LOG IN FOR FULL STORY)